The forecast for chronic liver diseases and cirrhosis mortality among women in Canada indicates a slight upward trend over the next five years. In 2023, the baseline was observed at 6.4 female deaths per hundred thousand women. Year-on-year growth from 2024 onwards shows a steady but marginal increase, with rates moving from 6.5 in 2024 to 6.7 by 2028. The compound annual growth rate (CAGR) over this period highlights a minimal increase, reflecting a gradually escalating mortality rate.
Future trends to watch for include potential public health interventions aimed at reducing alcohol consumption and hepatitis transmission, which could impact these projections. Additionally, advancements in medical treatments for liver diseases could shift trends positively.
